Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Adicet Bio Q3 EPS $(0.53) Down From $(0.44) YoY

Adicet Bio Q3 EPS $(0.53) Down From $(0.44) YoY

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.53) per share. This is a 20.45 percent decrease over losses of $(0.44) per share from the same period last year.

byBenzinga Newsdesk

November 8, 2022

1 minute read

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.53) per share. This is a 20.45 percent decrease over losses of $(0.44) per share from the same period last year.

Wedbush Downgrades Varonis Systems to Neutral, Lowers Price Target to $20

By Benzinga Newsdesk

November 1, 7:21 AM

Wedbush analyst Daniel Ives downgrades Varonis Systems (NASDAQ:VRNS) from Outperform to Neutral and lowers the price target from $40 to $20.

VRNS

Vertex Energy Files For Mixed-Securities Shelf Offering, Size Not Disclosed

By Michael Horton

September 30, 4:35 PM

-Reuters

VTNR

This Stock Earns Price Bump, Bullish Pitch On Recent Positive Migraine Drug Data

By Vandana Singh

September 21, 2:33 PM

Satsuma Pharmaceuticals Inc (NASDAQ:STSA) announced positive results from the ASCEND open-label, long-term safety trial for STS101 intranasal dry powder dihydroergotamine (DHE)…

STSA

Wells Fargo Maintains Equal-Weight on Scotts Miracle Gro, Raises Price Target to $60

By Benzinga Newsdesk

January 31, 8:42 AM

Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:SMG) with a Equal-Weight and raises the price target from $50 to $60.

SMG

Adicet Bio Q3 EPS $(0.53) Down From $(0.44) YoY

Related Posts

Wedbush Downgrades Varonis Systems to Neutral, Lowers Price Target to $20

Vertex Energy Files For Mixed-Securities Shelf Offering, Size Not Disclosed

This Stock Earns Price Bump, Bullish Pitch On Recent Positive Migraine Drug Data

Wells Fargo Maintains Equal-Weight on Scotts Miracle Gro, Raises Price Target to $60